{"id":61696,"date":"2025-08-06T16:05:32","date_gmt":"2025-08-06T14:05:32","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/"},"modified":"2025-08-06T16:05:32","modified_gmt":"2025-08-06T14:05:32","slug":"fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/","title":{"rendered":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries"},"content":{"rendered":"
\n

\nFederal agencies and research partners can slash months from ATO timelines by procuring COTS tools to launch health research projects faster<\/i><\/p>\n

<\/a>
<\/a><\/p>\n

FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP\u00ae) Moderate Authority to Operate (ATO) and is now available on the FedRAMP Marketplace<\/a>. This authorization affirms that Vibrent meets rigorous NIST 800-53 standards and HIPAA compliance requirements, including encryption, continuous monitoring, incident response, and privacy safeguards for protected health information (PHI) and personally identifiable information (PII) and other data.<\/p>\n

\nFederal agencies conducting health research involving federal data (such as NIH, BARDA, ARPA-H, VA, DHA, DoD, FDA, CDC, and others) must utilize FedRAMP-authorized cloud services<\/a>. Until now, agencies performing health and clinical research lacked FedRAMP-authorized common off-the-shelf (COTS) digital tools to meet their evolving needs. Vibrent\u2019s FedRAMP authorization streamlines procurement of these tools and services, allowing agencies to quickly initiate studies while eliminating redundant security reviews and drastically reducing participant recruitment times.<\/p>\n

\nVibrent\u2019s integrated digital health tools<\/a> support longitudinal research across cancer, chronic and autoimmune diseases, genomics, precision medicine, population health, and infectious diseases. These tools flexibly serve hybrid, decentralized, and remote studies conducted in clinical, community, and home settings.<\/p>\n

\n\u201cSecurity and participant trust are non-negotiable in health research,\u201d said Praduman Jain, CEO of Vibrent Health. \u201cFedRAMP authorization removes a barrier to collaboration with federal agencies. Studies launch faster, since the cloud environment has been vetted against the government\u2019s most demanding health data controls.\u201d<\/p>\n

\nVibrent\u2019s COTS software platform supports many large-scale government initiatives, including NIH All of Us<\/i> Research Program, NCI RADx, NIDCD, BARDA NextGen and RRPV, with capabilities that drive efficiency while using fewer resources. The Digital Health Research Platform tech stack includes digital recruitment and enrollment, participant engagement, secure multi-modal data collection, data integration with clinical and claims data, EHR and wearable data, genomics return of results, cloud-based central data management, study management dashboards and reports, HIPAA, and 21 CFR Part 11 regulatory compliance.<\/p>\n

\nVibrent\u2019s FedRAMP authorized platform is available for broad use<\/b><\/a> by federal agencies to support various health research studies, registries, and clinical trials.<\/b><\/p>\n

\nAbout Vibrent Health
\n
<\/b>Vibrent Digital Health Research Cloud for Government provides a comprehensive platform with tools for health research studies, trials, and registries. Its capabilities include participant recruitment, enrollment, engagement, data collection, EHR data access, data sharing, data management, workflow automation, and data analysis tools. The solution connects data across operational silos and reduces complexity while building a data ecosystem. It offers agencies the flexibility to scale while maintaining compliance with critical government standards. Powered by AWS, Vibrent Cloud can store and analyze highly sensitive government health research data with the hardened security and production-grade capabilities government agencies require. For more information, visit http:\/\/www.vibrenthealth.com\/<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nMolly Bryant, VP
\n
mbryant@vibrenthealth.com<\/a>
(843) 814-8623<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Federal agencies and research partners can slash months from ATO timelines by procuring COTS tools to launch health research projects faster FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP\u00ae) Moderate … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61696","6":"format-standard","7":"category-industry"},"yoast_head":"\nFedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Federal agencies and research partners can slash months from ATO timelines by procuring COTS tools to launch health research projects faster FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP\u00ae) Moderate ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-06T14:05:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries\",\"datePublished\":\"2025-08-06T14:05:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/\"},\"wordCount\":504,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250806550592\\\/en\\\/798625\\\/22\\\/VibrentLogo_C_H_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/\",\"name\":\"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250806550592\\\/en\\\/798625\\\/22\\\/VibrentLogo_C_H_RGB.jpg\",\"datePublished\":\"2025-08-06T14:05:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250806550592\\\/en\\\/798625\\\/22\\\/VibrentLogo_C_H_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250806550592\\\/en\\\/798625\\\/22\\\/VibrentLogo_C_H_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/","og_locale":"en_US","og_type":"article","og_title":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend","og_description":"Federal agencies and research partners can slash months from ATO timelines by procuring COTS tools to launch health research projects faster FAIRFAX, Va.–(BUSINESS WIRE)–Vibrent Health, the leading digital platform for next-generation precision health research, today announced that its Digital Health Research Cloud for Government has received a Federal Risk and Authorization Management Program (FedRAMP\u00ae) Moderate ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/","og_site_name":"Pharma Trend","article_published_time":"2025-08-06T14:05:32+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries","datePublished":"2025-08-06T14:05:32+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/"},"wordCount":504,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/","url":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/","name":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg","datePublished":"2025-08-06T14:05:32+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250806550592\/en\/798625\/22\/VibrentLogo_C_H_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/fedramp-authorizes-vibrent-healths-digital-health-research-cloud-for-us-government-clients-to-rapidly-launch-research-studies-clinical-trials-and-registries\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"FedRAMP Authorizes Vibrent Health\u2019s Digital Health Research Cloud for US Government Clients to Rapidly Launch Research Studies, Clinical Trials, and Registries"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61696"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61696\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}